ICD-10-CM code · FY2027

E09.339 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

Header codeNot billable: use one of the 4 billable codes below

About E09.339

Code
E09.339
Billable
No, header
Short description
Drug/chem diab w mod nonprlf diab rtnop w/o macular edema
Category
E09 Drug or chemical induced diabetes mellitus
Block
E08-E13 Diabetes mellitus
Chapter
4 Endocrine, nutritional and metabolic diseases
Code set
FY2027, October 1, 2026 to September 30, 2027
EvidencePulse™

Go deeper into drug-induced diabetes.

Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.

Ask EvidencePulse™

Coding notes for E09.339

No notes of its own; the notes below apply from the codes above it.

7th character Required: add one of these as the 7th character, with X as a placeholder to fill six characters.

CharacterMeaning
1right eye
2left eye
3bilateral
9unspecified eye

Also applies, from E09.33 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy

7th character

  • One of the following 7th characters is to be assigned to codes in subcategory E09.33 to designate laterality of the disease:

Also applies, from E09 Drug or chemical induced diabetes mellitus

Excludes1 Not coded here: never report these together with this code (use the code given instead).

  • diabetes mellitus due to underlying condition (E08.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)

Code first Report the underlying condition's code before this one.

  • poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Use additional code Add a second code for the detail named here.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)
Chapter 4 notes (apply to every code in it)

Note

  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Excludes1 Not coded here: never report these together with this code (use the code given instead).

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Codes under E09.339 4

Related codes in E09.33

Latest research on drug-induced diabetes

More Endocrinology from 2 Minute Medicine

2MM+

Read the research behind every diagnosis

2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.

See 2MM+ plans

ICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.